|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 157,50 ILa | -2,84% |
|
-8,38% | -47,60% |
| 02/06 | Biomica achève l'étude clinique de phase 1 du BMC128 en combinaison avec le Nivolumab | CI |
| 20/05 | Evogene Ltd. publie ses résultats pour le premier trimestre clos le 31 mars 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2,84% | -8,38% | -28,89% | -37,13% | -47,60% | -69,52% | -94,17% | -98,69% | -99,36% | 5,77 M | |
| -0,34% | -1,48% | +4,73% | +0,68% | -8,59% | -12,18% | -13,39% | -25,29% | +215,13% | 43,44 Md | |
| +3,31% | +13,04% | +11,90% | +64,42% | +104,63% | +316,43% | +562,02% | +378,82% | - | 33,54 Md | |
| -1,70% | -7,90% | -0,80% | -0,39% | -25,57% | +8,87% | -22,34% | -31,88% | +164,62% | 28,48 Md | |
| +2,84% | +2,48% | -7,88% | -5,98% | -11,08% | +6,32% | +34,93% | -17,92% | +768,65% | 29,2 Md | |
| -0,57% | +3,77% | -3,45% | -11,51% | +0,71% | +12,66% | +20,42% | -21,50% | +165,07% | 25,34 Md | |
| -0,14% | +10,03% | -4,02% | - | - | - | - | - | - | 14,36 Md | |
| +0,68% | -1,19% | +10,82% | +1,11% | -18,06% | +54,47% | +107,47% | +153,15% | - | 13,05 Md | |
| +0,54% | -3,88% | +6,07% | +1,06% | +0,77% | +3,69% | +2,24% | -30,64% | +99,30% | 12,67 Md | |
| -0,26% | +1,09% | -0,15% | +2,47% | -6,31% | +105,03% | +80,69% | +97,76% | +230,01% | 12,28 Md | |
| +1,91% | +0,98% | +25,45% | +45,29% | -19,88% | +2,92% | -37,64% | -32,91% | +128,02% | 10,97 Md | |
| +4,20% | +2,75% | +15,73% | 0,00% | -13,90% | -27,49% | - | - | - | 8,76 Md | |
| +1,46% | -0,69% | +22,64% | +20,36% | -7,26% | +27,54% | -11,90% | -48,29% | +125,36% | 8,78 Md | |
| +5,35% | +10,36% | +33,81% | +13,47% | -1,48% | +17,05% | -26,18% | -47,94% | +110,42% | 8,61 Md | |
| +0,14% | -.--% | -.--% | -.--% | -.--% | +0,96% | +111,16% | +54,99% | +611,71% | 8,38 Md | |
| -18,96% | -41,27% | -57,98% | -47,71% | -42,81% | -84,60% | +1 807,86% | - | - | 7,34 Md | |
| -2,38% | +2,50% | -12,97% | -21,35% | -28,41% | +1 425,66% | +442,14% | +185,43% | +890,80% | 8,16 Md | |
| +1,01% | -0,19% | +12,04% | -11,05% | -21,94% | -24,59% | -29,21% | -29,22% | +54,67% | 7,56 Md | |
| +1,08% | +2,62% | +20,04% | +62,71% | +60,79% | +51,13% | +39,76% | +82,22% | +8,75% | 7,42 Md | |
| +0,59% | +15,60% | +10,00% | +11,35% | +16,22% | +95,10% | +249,69% | +89,74% | - | 7,39 Md | |
| Moyenne | -0,59% | -0,27% | +2,85% | +4,62% | -3,67% | +100,50% | +179,09% | +38,69% | +248,08% | 14,79 Md | |
| Moyenne pondérée par Capi. | -0,11% | +0,40% | +3,76% | +8,90% | +4,41% | +88,78% | +148,85% | +53,79% | +289,03% |
- Bourse
- Actions
- Action EVGN
- Secteur Evogene Ltd.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
